Tradestie Institutional Equity Comparison Engine

RADX vs AAUS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RADX Overall Edge

RADX Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Radiopharm Theranostics Limited American Depositary Shares (RADX) driven by superior Growth & Margin while AAUS counters with relative strength in Momentum & Technical. Fundamentally, RADX trades at N/M Forward P/E with -411.6% operating margin (-36.9% YoY revenue) versus AAUS at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AAUS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RADX N/M vs AAUS N/M Fwd P/E
Growth & Margin Winner RADX
Op Margin -411.6% vs N/A ยท YoY -36.9% vs N/A
Momentum & Technical Winner AAUS
1Y -86.0% vs +1.5% ยท 52W Pos 0% vs 32%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RADX NASDAQ
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
$0.63
-6.33% 1D
Market Cap $10.6M
1M Return -33.64%
1Y Return -86.04%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
AAUS US Equity
AAUS
Institutional Equity
$55.08
-3.9% 1D
Market Cap N/A
1M Return -10.24%
1Y Return +1.53%
Forward P/E N/M
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RADX -86.04% AAUS +1.53% Spread: +88.19 pp (AAUS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RADX TTM Op. Margin: -411.6% AAUS TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RADX vs AAUS. Trailing 12-month operating profitability (RADX -411.6% vs AAUS N/A) and valuation multiples (RADX N/M vs AAUS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RADX (5) vs AAUS (3)
Institutional Metric RADX AAUS Criterion Row Winner
Market Capitalization Scale $10.6M N/A Larger Scale RADX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -36.9% N/A Higher Growth RADX
Operating Margin (TTM) Profitability -411.6% N/A Higher Margin RADX
Net Profit Margin Profitability 0.0% N/A Higher Margin RADX
Return on Equity (ROE) Capital Efficiency -174.7% N/A Higher ROE RADX
52-Week Range Position Momentum 0% ($1โ€“$16) 32% ($51โ€“$64) Stronger Trend AAUS
Beta / 30D Volatility Risk Regime 0.52ฮฒ ยท 109% Vol 0.97ฮฒ ยท 24% Vol Lower Realized Risk AAUS
Unified Institutional Score Composite Signal 41.1 / 100 (SELL) 43.4 / 100 (HOLD) Higher Composite AAUS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RADX vs AAUS Buy Guide
RADX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RADX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AAUS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RADX nor AAUS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.